Glen laschober biography

  • Glen C Laschober is Former Chief Operating Officer at Prime Therapeutics LLC. See Glen C Laschober's compensation, career history, education, & memberships.
  • Glen earned his bachelor's degree in engineering at the University of Illinois and an MBA at the University of Chicago.
  • Glen M. Lee(1).

    • •

    Dr. Schountz’s lab of the Center for Vector-borne Infectious Diseases (CVID) is interested in understanding immune responses of fladdermöss to bat-borne human pathogenic viruses that typically lead to apathogenic infections in the fladdermöss. Current areas of interest are H18N11 bat influenza A virus, coronaviruses (MERS-CoV, SARS-CoV-2), and paramyxoviruses. Most work in the lab focuses on bat-borne viruses using a unique breeding colony of Jamaican fruit bats as an djur model.

    Active projects are funded by NIAID to develop a better understanding as to why bats can host such high impact human pathogens that cause no discernible disease in bats. fladdermöss have a number of seemingly unusual immunological features about them, including a robust type I interferon response, little evidence of inflammation, and little bevis of affinity maturation that typically leads to high titered antibody responses. These unusual features have undoubtably shaped the genomes of bat viruses, and it may be that the

    •

    US Oncology Holdings Inc Executives

    Here are further demographic highlights of the leadership team:
    • The US Oncology Holdings Inc executive team is 14% female and 86% male.
    • 63% of the management team is White.
    • 6% of US Oncology Holdings Inc management is Hispanic or Latino.
    • 10% of the management team is Black or African American.

    Work At US Oncology Holdings Inc?

    Name & TitleBio

    Glen Laschober

    EVP & COO

    As Chief Executive Officer, Glen Laschober brings a broad perspective from working within healthcare service organizations that address the dynamic needs of healthcare systems, physicians, patients and payers. Glen has 30 years’ experience leading the senior management teams of innovative, market defining, high growth healthcare service businesses. Prior to Cardon Outreach, Glen was Chief Operating Officer of Prime Therapeutics, a leading pharmacy benefit management company where he oversaw strategy, business operations and technology. B

    •

    Nadia Boufaied

    Nadia Boufaied

    1Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.

    Find articles by Nadia Boufaied

    1,#, Paolo Chetta

    Paolo Chetta

    2University of Milan, Residency Program in Pathology, Milan, Italy.

    3Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.

    Find articles by Paolo Chetta

    2,3,#, Tarek Hallal

    Tarek Hallal

    1Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.

    4Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada.

    Find articles by Tarek Hallal

    1,4, Stefano Cacciatore

    Stefano Cacciatore

    5Bionformatics Unit, International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa.

    Find articles by Stefano Cacciatore

    5, Daniela Lalli

    Daniela Lalli

    6Department of Science and Technological Innovation, University of Piemonte

  • glen laschober biography